Your browser doesn't support javascript.
loading
Chinese Chronic Mucocutaneous Candidiasis: A Case Report Series.
Qian, Guocheng; Zhang, Jiaying; Shi, Leyao; Li, Dongmei; Yang, Biao; Chen, Biao; Shi, Dongmei.
Affiliation
  • Qian G; The Second Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China.
  • Zhang J; School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, People's Republic of China.
  • Shi L; The Second Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China.
  • Li D; Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, USA.
  • Yang B; Laboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong Province, People's Republic of China.
  • Chen B; Department of Dermatology, Jining No. 1 People's Hospital, Jining, Shandong Province, People's Republic of China.
  • Shi D; Laboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong Province, People's Republic of China.
Infect Drug Resist ; 17: 1869-1877, 2024.
Article in En | MEDLINE | ID: mdl-38745679
ABSTRACT
Chronic Mucocutaneous Candidiasis (CMC) is a rare immunodeficiency disease characterized by chronic or recurrent superficial Candida infections on the skin, nail, and mucous membranes. Here, we present four Chinese patients with CMC who manifested oral mucosal leukoplakia and nail thickening during early childhood, all displaying fissured tongue lines. The causative pathogens isolated from their oral mucosa and nails were identified as C. albicans and C. parapsilosis through morphology and molecular sequencing. Notably, among the four patients, one presented with vitiligo, while another had hypothyroidism. We have also conducted a review of reported cases of CMC in China and worldwide over the last five years, highlighting potential approaches for diagnosis and treatment. The current molecular evidence in the literature suggests potential for the development of early diagnosis methods, such as screening genetic variables on STAT1 and STAT3. Additionally, potential treatment avenues, including gene-targeted analogues and GM-CSF analogues, could be explored in conjunction with traditional antifungal therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Drug Resist Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Drug Resist Year: 2024 Document type: Article